FDA Expedited Investigational ... Note

FDA Expedited Investigational New Drug (IND) Pilot Program

The FDA Expedited IND Pilot Program is an initiative under HHS Operation TrialBlazer designed to evaluate new approaches for accelerating first-in-human (FIH) clinical trials in the United States while maintaining FDA's rigorous standards for participant safety and scientific oversight.